Brand
Deva Holding As - Cerkezkoy Subesi Recalls
6 recalls on record. Search official CPSC, FDA, and USDA datasets for every recall issued for Deva Holding As - Cerkezkoy Subesi.
6Total Recalls
0Critical
54,768Units Affected
Jul 16, 2019Most Recent
All Recalls
Every Deva Holding As - Cerkezkoy Subesi Recall
Sorted by most recent. Click any recall for full details.
6 recalls
High RiskFDA
Deva Holding As - Cerkezkoy Subesi
Temozolomide Capsules, 180 mg, packaged in a) 5-count bottle (NDC 67877-541-07), b) 14-count bottle (NDC 67877-541-14), Rx only, Manufact...
Oral Drugs5,052 affectedJul 16, 2019
High RiskFDA
Deva Holding As - Cerkezkoy Subesi
Temozolomide Capsules, 100 mg, packaged in a) 5-count bottle (NDC 67877-539-07), b) 14-count bottle (NDC 67877-539-14), Rx only, Manufact...
Oral Drugs13,752 affectedJul 16, 2019
High RiskFDA
Deva Holding As - Cerkezkoy Subesi
Temozolomide Capsules, 20 mg, packaged in a) 5-count bottle (NDC 67877-538-07), b) 14-count bottle (NDC 67877-538-14), Rx only, Manufactu...
Oral Drugs11,376 affectedJul 16, 2019
High RiskFDA
Deva Holding As - Cerkezkoy Subesi
Temozolomide Capsules, 250 mg, 5-count bottle, Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, D...
Oral Drugs11,472 affectedJul 16, 2019
High RiskFDA
Deva Holding As - Cerkezkoy Subesi
Temozolomide Capsules, 140 mg, packaged in a) 5-count bottle (NDC 67877-540-07), b) 14-count bottle (NDC 67877-540-14), Rx only, Manufact...
Oral Drugs7,380 affectedJul 16, 2019
High RiskFDA
Deva Holding As - Cerkezkoy Subesi
Temozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 67877-537-07), b) 14-count bottle (NDC 67877-537-14), Rx only, Manufactur...
Oral Drugs5,736 affectedJul 16, 2019